Loading
NASDAQBasic MaterialsAgricultural Inputs
Latest quote
$0.287
−$0.011 · -3.69%
Arcadia Biosciences, Inc. is a U.S.-based company that provides plant-derived health and well-being products. Additionally, it is actively engaged in agricultural research and development, with a particular focus on improving wheat crops. The aim of these innovations is to enhance farmers' economic stability by boosting crop performance in the field, increasing their value for food and wellness applications, and expanding their potential for industrial uses. Established in 2002, the company's main office is located in Davis, California.
Previous close
$0.287
−$0.011 · -3.69%
Pre-market
$0.2899
+$0.0029 · +1.01%
Oct 8, 8:11 AM ET
Regular session · ET · Market data may be delayed.
Arcadia Biosciences, Inc. is a U.S.-based company that provides plant-derived health and well-being products. Additionally, it is actively engaged in agricultural research and development, with a particular focus on improving wheat crops. The aim of these innovations is to enhance farmers' economic stability by boosting crop performance in the field, increasing their value for food and wellness applications, and expanding their potential for industrial uses. Established in 2002, the company's main office is located in Davis, California.
Day range
Current $0.287
52-week range
Current $0.287
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
44
Fair Value
Sentiment
39
Bearish
Risk
64
High Risk
Momentum
17
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Arcadia Biosciences, Inc. is a U.S.-based company that provides plant-derived health and well-being products. Additionally, it is actively engaged in agricultural research and development, with a particular focus on improving wheat crops. The aim of these innovations is to enhance farmers' economic stability by boosting crop performance in the field, increasing their value for food and wellness applications, and expanding their potential for industrial uses. Established in 2002, the company's main office is located in Davis, California.
Day range
Current $0.287
52-week range
Current $0.287
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.86M USD | 5.05M USD | 4.45M USD | 7.42M USD | 6.78M USD |
| Cost of goods sold | 3.1M USD | 2.96M USD | 2.17M USD | 6.1M USD | 8.71M USD |
| Gross profit | 1.76M USD | 2.08M USD | 2.28M USD | 1.32M USD | −1.93M USD |
| Research and development | 9K USD | 53K USD | 64K USD | 1.51M USD | 3.89M USD |
| Selling, general, and administrative | 7M USD | 9.64M USD | 8.23M USD | 15.04M USD | 22.94M USD |
| Operating expenses | 11.76M USD | 5.73M USD | 8.38M USD | 15.32M USD | 33.6M USD |
| Interest income | 221K USD | 782K USD | 695K USD | 289K USD | — |
| Interest expense | — | — | — | — | 20K USD |
| Depreciation and amortization | 32K USD | 765K USD | 287K USD | 479K USD | 1.05M USD |
| Operating income | −10M USD | −3.65M USD | −6.1M USD | −14.01M USD | −35.53M USD |
| Net income | −2.34M USD | −7.04M USD | −13.98M USD | −15.38M USD | −14.66M USD |
Company facts updated Oct 8, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$6.00
1990.59% upside| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Mar 1, 2023 | 1:40 | — | — |
Stock split | Jan 24, 2018 | 1:20 | — | — |
Effective Mar 1, 2023
1:40
Effective Jan 24, 2018
1:20
Funds reporting this stock among their holdings, ordered by reported position size.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
